Abstract Pens and autoinjectors are mainly used for the subcutaneous delivery of biopharmaceuticals, primarily for self-administration by the patient
-Olivia Johnson, 37 years old, Seattle, USA Why is GL-1 8--1 & your great choice
Sources & References Eli Lilly press release: Lilly's triple agonist, retatrutide, successful in two additional Phase 3 obesity trials, delivering significant improvements in weight and A1C
For most people, side effects are limited to mild soreness or tenderness at the injection site that fades within a few days
Clinical pharmacology biopharmaceutics review: Byetta
Again, if you experience any severe side effects (such as anaphylaxis or shortness of breath), seek immediate medical advice from a healthcare professional